White Blood Cell Count and the Risk of Colon Cancer
1
조회
0
다운로드
0
인용
0
참고문헌
초록
Inflammation may be linked to the pathogenesis of colorectal cancer. However, two conflicting observational results were recently reported on the relationship between the inflammatory marker C-reactive protein (CRP) and the risk of colorectal cancer. Few epidemiologic studies have examined the association between inflammatory markers and the risk of colorectal cancer. We prospectively examined the mortality and incidence risk for colon and rectal cancers among 424,419 Koreans (108,907 men and 315,512 women). The subjects were 40 to 95 years of age and from the Korean Cancer Prevention Study (KCPS) cohort. All subjects received medical examination from the National Health Insurance Corporation in 1993 and 1995. The maximum follow-up period was 10 years, and the follow-up periods began in January 1, 1994 and ended in December 31, 2003. An elevated white blood cell count (WBC) was associated with a higher mortality risk of colon cancer (highest versus lowest quartile: men, 1.55, 95% CI 1.10-2.18, p for trend=0.0014; women, 1.51, 95% CI 1.12- 2.03, p for trend=0.0049). Similarly, an elevated WBC was associated with a higher incidence risk of colon cancer (highest versus lowest quartile: men, 1.38, 1.09-1.76, p for trend=0.0017; women, 1.46, 95% CI 1.20-1.78, p for trend= 0.0003). A positive linear trend was also observed in non- smokers. There was no significant association between WBC and the risk of rectal cancer. Our findings demonstrate that an elevated WBC is associated with an increase in both the mortality and incidence rates of colon cancer. These results support our hypothesis that inflammation increases the risk of colon cancer.
Abstract
Inflammation may be linked to the pathogenesis of colorectal cancer. However, two conflicting observational results were recently reported on the relationship between the inflammatory marker C-reactive protein (CRP) and the risk of colorectal cancer. Few epidemiologic studies have examined the association between inflammatory markers and the risk of colorectal cancer. We prospectively examined the mortality and incidence risk for colon and rectal cancers among 424,419 Koreans (108,907 men and 315,512 women). The subjects were 40 to 95 years of age and from the Korean Cancer Prevention Study (KCPS) cohort. All subjects received medical examination from the National Health Insurance Corporation in 1993 and 1995. The maximum follow-up period was 10 years, and the follow-up periods began in January 1, 1994 and ended in December 31, 2003. An elevated white blood cell count (WBC) was associated with a higher mortality risk of colon cancer (highest versus lowest quartile: men, 1.55, 95% CI 1.10-2.18, p for trend=0.0014; women, 1.51, 95% CI 1.12- 2.03, p for trend=0.0049). Similarly, an elevated WBC was associated with a higher incidence risk of colon cancer (highest versus lowest quartile: men, 1.38, 1.09-1.76, p for trend=0.0017; women, 1.46, 95% CI 1.20-1.78, p for trend= 0.0003). A positive linear trend was also observed in non- smokers. There was no significant association between WBC and the risk of rectal cancer. Our findings demonstrate that an elevated WBC is associated with an increase in both the mortality and incidence rates of colon cancer. These results support our hypothesis that inflammation increases the risk of colon cancer.
참고문헌 (27)
- "2002 Annual report of the Korea central cancer registry" (2003), Goyang: National Cancer Information Center, 2003
- "Death Statistics based on vital registration 2002" (2003), Daejeon: Korea National Statistical Office, 2003
- "Family history and molecular features of children, adolescents and young adults with colorectal carcinoma", 54, pp.1146~1150 (2005)
- "BMI and waist circumference as predictors of lifetime colon cancer risk in Framingham Study adults", 28, pp.559~567 (2004)
- "Diet and colorectal adenoma in Japanese males and females", 44, pp.105~111 (2001)
- "Height, weight, and alcohol consumption in relation to the risk of colorectal cancer in Japan: a prospective study", 88, pp.1038~1043 (2003)
- "Cigarette smoking and colorectal cancer: APC mutations, hMLH1 expression, and GSTM1 and GSTT1 polymorphisms", 161, pp.806~815 (2005)
- "Physical activity and colorectal cancer", 158, pp.214~224 (2003)
- "Fasting serum glucose level and cancer risk in Korean men and women", 293, pp.194~202 (2005)
- "Aspirin use and the risk for colorectal cancer and adenoma in male health professionals", pp.241~6
- "Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis", pp.1313~6
- "C-reactive protein and the risk of incident colorectal cancer", 291, pp.585~590 (2004)
- "C-reactive protein levels are not associated with increased risk for colorectal cancer in women", 142, pp.425~432 (2005)
- "Raised C-reactive protein levels in serum from smokers", pp.9~13, Clin Chim Acta 1985
- "A randomized trial of aspirin to prevent colorectal adenomas", 348, pp.891~899 (2003)
- "WBC and the risk of cancer mortality in a national sample of U.S. adults", 13, pp.1052~1056 (2004)
- "Prostaglandin E2 levels and lymphocyte subsets in portal venous drainage of colorectal cancers", pp.264~7
- "Patients with adenomatous polyps and carcinomas have increased colonic mucosal prostaglandin E2", pp.675~8
- "Vascular-specific growth factors and blood vessel formation", 407, pp.242~248 (2000)
- "Cyclooxygenase regulates angiogenesis induced by colon cancer cells", 93, pp.705~716 (1998)
- "Nitric oxide and oxygen radicals in infection, inflammation, and cancer", 63, pp.854~865 (1998)
- "The initiation of colon cancer in a chronic inflammatory setting", rabi(vitch ps), pp.1513~9
- "Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells", 58, pp.362~366 (1998)
- "Association between leisure time physical activity and markers of chronic inflammation related to coronary heart disease", 176, pp.303~310 (2004)
- "Prediction of glucose and insulin responses of normal subjects after consuming mixed meals varying in energy, protein, fat, carbohydrate and glycemic index", 126, pp.2807~2812 (1996)
- "A prospective study of plasma C- peptide and colorectal cancer risk in men", 96, pp.546~553 (2004)
- "Bowel inflammation as measured by fecal calprotectin: a link between lifestyle factors and colorectal cancer risk", 13, pp.279~284 (2004)